tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Srikripa Devarakonda, 94 are a BUY (91.26%), 9 are a HOLD (8.74%).
Analyst Srikripa Devarakonda, currently employed at TRUIST, carries an average stock price target met ratio of 54.89% that have a potential upside of 33.68% achieved within 156 days.
Srikripa Devarakonda’s has documented 201 price targets and ratings displayed on 18 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on SRRK, Scholar Rock Holding Corp at 04-Mar-2026.
Analyst best performing recommendations are on TERN (TERNS PHARMACEUTICALS).
The best stock recommendation documented was for TERN (TERNS PHARMACEUTICALS) at 10/15/2025. The price target of $20 was fulfilled within 27 days with a profit of $11.5 (135.29%) receiving and performance score of 50.11.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 24-Nov-2025
$117
$26.22 (28.88%)
$116
1 months 3 days ago
(18-Feb-2026)
0/3 (0%)
$14.01 (13.60%)
Hold Since 10-Apr-2023
$92
$1.22 (1.34%)
$84
1 months 10 days ago
(11-Feb-2026)
42/49 (85.71%)
$-6.84 (-6.92%)
353
Hold Since 20-Jan-2026
$101
$10.22 (11.26%)
$107
1 months 10 days ago
(11-Feb-2026)
11/13 (84.62%)
$2.16 (2.19%)
39
Buy Since 16-Jun-2025
$120
$29.22 (32.19%)
$115
1 months 10 days ago
(11-Feb-2026)
8/10 (80%)
$21.16 (21.41%)
197
Buy Since 08-Feb-2023
$128
$37.22 (41.00%)
$101
2 months 8 days ago
(13-Jan-2026)
9/10 (90%)
$24.57 (23.76%)
370
Which stock is Srikripa Devarakonda is most bullish on?
Which stock is Srikripa Devarakonda is most reserved on?
What Year was the first public recommendation made by Srikripa Devarakonda?
